Boothwyn Pharmacy recalled 186 vials of Semaglutide, 2.5 mg/mL injection on July 9, 2025. The product is subpotent and poses a risk to consumers. Healthcare providers and consumers should stop using this product immediately.
Subpotent Drug
Consumers and healthcare providers should stop using this product immediately. Contact Boothwyn Pharmacy LLC or your healthcare provider for guidance. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Semaglutide, 2.5 mg/mL injection, 0.8 mL, is sold under the brand Boothwyn Pharmacy. The recall affects 186 vials distributed nationwide in the U.S. The recall was classified as Class II.
The recalled Semaglutide injection may not provide the intended therapeutic effect due to being subpotent. This could lead to inadequate treatment for conditions it is prescribed for, potentially impacting patient health.
No specific incidents or injuries have been reported related to this recall. The risk remains high due to the possibility of ineffective treatment.
Consumers should stop using the recalled Semaglutide injection immediately. Contact Boothwyn Pharmacy LLC or your healthcare provider for further guidance.
For more information, contact Boothwyn Pharmacy LLC via email or phone. Additional details are available at the FDA's recall page.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.